Papular elastorrhexis

disease
On this page

Also known as disseminated nevus anelasticuseruptive collagenomaNevus anelasticus

Summary

Papular elastorrhexis (MONDO:0016443) is a disease. A subtype of dermis disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Europe)

Clinical features

Epidemiology

Prevalence records

1 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Point prevalence<1 / 1 000 000EuropeNot yet validated

Identifiers

Disease identifiers

FieldValue
Canonical namepapular elastorrhexis
Mondo IDMONDO:0016443
Orphanet228264
ICD-111231672259
NCITC4707
SNOMED CT239138008
UMLSC5680907
MedGen1813032
GARD0020583
Is cancer (heuristic)no

Also known as: disseminated nevus anelasticus · eruptive collagenoma · Nevus anelasticus

Disease family

Classification path: disease › human disease › disease by body system or component › integumentary system disorder › skin disorder › dermis disorder › papular elastorrhexis

Related subtypes (27): dermis tumor, necrobiosis lipoidica, isolated anhidrosis with normal sweat glands, familial cutaneous collagenoma, elastosis perforans serpiginosa, progressive osseous heteroplasia, antecubital pterygium syndrome, familial reactive perforating collagenosis, dermochondrocorneal dystrophy, lipoid proteinosis, primary cutaneous amyloidosis, linear atrophoderma of Moulin, confetti-like macular atrophy, late-onset focal dermal elastosis, linear focal dermal elastosis, elastoderma, elastoma, primary anetoderma, familial anetoderma, white fibrous papulosis of the neck, mid-dermal elastolysis, lichen myxedematosus, pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa, primary cutis verticis gyrata, mixed dermis disorder, atrophoderma of Pierini and Pasini, annular erythema of infancy

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.